Geyser Brands One Step Away From Solace Acquisition
August 21st, 2019
App, Exclusive, News, Top News, Uncategorized
After announcing its intent to acquire Solace Management Group Inc. and its suite of brands back in February, British Columbia-based Geyser Brands Inc. (TSXV: GYSR) has just been awarded conditional approval by the TSX, and expects the transaction to be completed by the end of August, pending final approval from the Exchange through a simple majority of the company’s shareholders.
Geyser is a Health Canada-approved Licensed Producer based in Vancouver, BC, which began trading on the TSXV in December. The company is actively engaged in building a leading cannabis healthcare company with a diverse portfolio of products in the lucrative health & wellness industry – including a range of products to promote pet health. The Solace acquisition is a key part of the company’s overall strategic plan, the foundation of a diverse domestic and international cannabis-powered consumer healthcare brand portfolio with equity in the red-hot medical, pet, cosmeceutical, and nutraceutical markets.
Commenting on the announcement, Geyser CEO Andreas Thatcher, said, “The management team at Solace has an exemplary track record in building businesses in the health-related cannabis industry. This conditional approval brings us one step closer to our intended goal of extending these businesses into the regulated cannabis space, and into world markets. Geyser Brands will be proud to associate with and support the team that continues to lead the cannabis industry through innovation and customer loyalty.”
Solace Vastly Expands, Diversifies Geyser Offering
Solace’s portfolio of brands range from hemp-infused consumer cosmetics and daily use products to hemp-infused pet health & wellness products (including the Apawthecary Pets line, Canada’s leading hemp-infused pet brand). Solace sets a high bar for consumer healthcare using cannabis-infused products through emphasis on quality, effectiveness, reliability, and convenience.
The Apawthecary Pets brand alone produces human-grade, all-natural hemp-based pet treats, salves, and oral drops currently sold in over 400 pet stores and 100 veterinary clinics across Canada. Solace has also developed WildTails, the first freeze-dried hemp-infused pet food, which includes pet treats, kibble, and food for dogs and cats, scheduled for release in Canada, the US, UK, and Japan later this year. Pet health & wellness is projected to be among the fastest growing sectors of the red-hot CBD market, and products to address anxiety, inflammation and pain are the leading segments in the industry.
Apothecary Naturals is a line of 100% natural hemp-based topical products, pain creams, cosmetics, organic soaps, lip balms, and men’s grooming and self-care products. Solace was initially inspired by Gabriele Jerousek, an advocate for the benefits of medical cannabis and the subsidiary’s CEO, who grew up helping her grandmother heal people with custom formulated tinctures, healing herbs, and topicals in her Viennese apothecary.
Apothecary Ink is a line of all-natural hemp-based numbing creams and tattoo aftercare products (for new and old tattoos, alike).
Solace also has a research and development arm, engaged in technology and formulation development for beverages, topicals, cosmetics, and other cannabis and hemp-infused nutraceutical products. Apothecary’s caplets, tinctures, and buccal sprays are condition-based, and formulated, produced, and tested by its team of scientists and researchers.
Facilities Gearing Up
In anticipation of expanded license approvals, Geyser’s wholly-owned Licensed Producer, 0957102 B.C. Ltd. dba Apothecary Botanicals made significant modifications to its 7,000 sq ft. licensed facility in Port Coquitlam, BC, and after being certified compliant with Health Canada standards in March, received its processing license, allowing it to begin manufacturing premier cannabis oils, tinctures and capsules. .
The company is also developing its manufacturing and R&D capabilities to provide in-house formulated products for future brands and Geyser’s white label products. The company expects to receive both its sales and research licenses shortly, allowing it to bring its science-backed, extract-infused products to market.
Solace recently moved to a new 7,500 sq. ft. facility, built to Good Manufacturing Practices (GMP) standards, in order to increase Solace’s production capacity ahead of the acquisition, to meet growing demand and allow the development of new products and formulations.
NanoFusion A Key Ingredient
A key challenge in producing cannabinoids for ingestion or absorption through the skin is their insolubility; due to their oily composition, they are naturally hydrophobic, meaning that their molecules are water-repellant, making it difficult for the body to absorb them, and the result is inconsistent, unreliable dosing and onset times of up to three hours.
All of the products in Geyser’s diverse portfolio are produced using its disruptive NanoFusion technology, making them more reliable and consistent, requiring smaller doses to deliver desired health & wellness results, increasing bioavailability and skin permeation, and greatly reducing the speed of onset.
NanoFusion also improves the transport of active ingredients for site-specific targeting by delivering active ingredients across cell membranes for release within the cell, and release times can be adjusted based on the delivery method. It also increases the stability of molecules, giving the company’s products a longer shelf-life than those produced using traditional methods.
Geyser’s proprietary NanoFusion formulations will be licensed across its own brand portfolio, but also to other brands in the market as an additional revenue stream.
Geyser Brands will utilize both of its GMP- licensed facilities in British Columbia for the manufacturing and distribution of its hemp and CBD-based products nationally and internationally, and should appeal to investors looking to get in on the ground floor with a company on the cusp of big developments, with the potential for rapid growth, a diverse array of products in all aspects of the cannabis market, and a detailed plan for expansion.
For more information, keep watching this page, and visit https://www.geyserbrands.com/
CannabisFN.com is not an independent financial investment advisor or broker-dealer. You should always consult with your own independent legal, tax, and/or investment professionals before making any investment decisions. The information provided on https://www.cannabisfn.com(the ‘Site’) is either original financial news or paid advertisements drafted by our in-house team or provided by an affiliate. CannabisFN.com, a financial news media and marketing firm enters into media buys or service agreements with the companies that are the subject of the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider. We make no warranty or representation about the information including its completeness, accuracy, truthfulness or reliability and we disclaim, expressly and implicitly, all warranties of any kind, including whether the Information is complete, accurate, truthful, or reliable. As such, your use of the information is at your own risk. Nor do we undertake any obligation to update the items posted. CannabisFN.com received compensation for producing and presenting high quality and sophisticated content on CannabisFN.com along with financial and corporate news.
This article was published by CFN Enterprises Inc. (OTCQB: CNFN), owner and operator of CFN Media, the industry’s leading agency and digital financial media network dedicated to the burgeoning CBD and legal cannabis industries. Call +1 (833) 420-CNFN for more information.
Follow Us on Social Media
About CFN Media Group
CFN Enterprises Inc. (OTCQB: CNFN) owns and operates CFN Media Group, the premier agency and financial media network reaching executives, entrepreneurs and consumers worldwide. Through its proprietary content creation, video library, and distribution via www.CannabisFN.com, CFN has built an extensive database of cannabis interest, assisting many of the world’s largest cannabis firms and CBD brands to build awareness and thrive. For more information, please visit www.cfnenterprisesinc.com.
Disclaimer: Matters discussed on this website contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time-to-time have a position in the securities mentioned herein and will increase or decrease such positions without notice. The Information contains forward-looking statements, i.e. statements or discussions that constitute predictions, expectations, beliefs, plans, estimates, or projections as indicated by such words as "expects", "will", "anticipates", and "estimates"; therefore, you should proceed with extreme caution in relying upon such statements and conduct a full investigation of the Information and the Profiled Issuer as well as any such forward-looking statements. Any forward looking statements we make in the Information are limited to the time period in which they are made, and we do not undertake to update forward looking statements that may change at any time; The Information is presented only as a brief "snapshot" of the Profiled Issuer and should only be used, at most, and if at all, as a starting point for you to conduct a thorough investigation of the Profiled Issuer and its securities and to consult your financial, legal or other adviser(s) and avail yourself of the filings and information that may be accessed at www.sec.gov, www.pinksheets.com, www.otcmarkets.com or other electronic sources, including: (a) reviewing SEC periodic reports (Forms 10-Q and 10-K), reports of material events (Form 8-K), insider reports (Forms 3, 4, 5 and Schedule 13D); (b) reviewing Information and Disclosure Statements and unaudited financial reports filed with the Pink Sheets or www.otcmarkets.com; (c) obtaining and reviewing publicly available information contained in commonlyknown search engines such as Google; and (d) consulting investment guides at www.sec.gov and www.finra.com. You should always be cognizant that the Profiled Issuers may not be current in their reporting obligations with the SEC and OTCMarkets and/or have negative signs at www.otcmarkets.com (See section below titled "Risks Related to the Profiled Issuers, which provides additional information pertaining thereto). For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity-based compensation in the companies it writes about, or a combination of the two. For full disclosure, please visit: https://www.cannabisfn.com/legal-disclaimer/. A short time after we acquire the securities of the foregoing company, we may publish the (favorable) information about the issuer referenced above advising others, including you, to purchase; and while doing so, we may sell the securities we acquired. In addition, a third-party shareholder compensating us may sell his or her shares of the issuer while we are publishing favorable information about the issuer. Except for the historical information presented herein, matters discussed in this article contain forward-looking statements that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. CFN Media Group, which owns CannabisFN, is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment advice or recommendations to readers of this release. CFN Media Group, which owns CannabisFN, may from time to time have a position in the securities mentioned herein and will increase or decrease such positions without notice. For making specific investment decisions, readers should seek their own advice and that of their own professional advisers. CFN Media Group, which owns CannabisFN, may be compensated for its Services in the form of cash-based and/or equity- based compensation in the companies it writes about, or a combination of the two. For full disclosure please visit: https://www.cannabisfn.com/legal-disclaimer/.